Department of Neurosurgery, The Third Afliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Department of Eye Tumor and Orbital Disease, Zhongshan Ophthalmic Center (ZOC) of Sun Yat-Sen University, Guangzhou, China.
World Neurosurg. 2024 Jan;181:e648-e654. doi: 10.1016/j.wneu.2023.10.105. Epub 2023 Oct 28.
For unilateral Dodge Class Ⅰ optic pathway glioma (OPG-uDCⅠ) without neurofibromatosis type 1, unilateral isolated optic nerve gliomas before the optic chiasm have been confirmed to possibly cause visual deterioration and poor prognosis. For this type of highly selective localized tumor, we explored surgery as the only treatment method. This article retrospectively analyzed and summarized the clinical data of this case series, with the aim of exploring the main technical details and clinical prognosis.
Included were patients with OPG-uDCⅠ without neurofibromatosis type 1 and experiencing vision loss on the affected side. The fronto-orbital approach was used, which was mainly divided into 3 parts: intraorbital, optic canal, and intracranial. All patients underwent prechiasmatic resection without any adjuvant treatments. The follow-up period was 3 months after surgery, and magnetic resonance imaging and contralateral visual acuity were reviewed annually after surgery.
All OPG-uDCⅠ cases were completely removed without any adjuvant treatments, and there was no recurrence during the follow-up period. Pathological results showed that, except for 1 adult patient with pilomyxoid astrocytoma (World Health Organization grade Ⅱ), the others all had pilocytic astrocytoma (World Health Organization grade Ⅰ). Five patients experienced transient ptosis, and all recovered 3 months after surgery.
For OPG-uDCⅠ without neurofibromatosis type 1, radical prechiasmatic resection of the tumor is possible, without the need for postoperative radiotherapy and chemotherapy.
对于无神经纤维瘤病 1 型的单侧 Dodge Ⅰ级视神经通路胶质瘤(OPG-uDCⅠ),单侧孤立的视交叉前视神经胶质瘤已被证实可能导致视力恶化和预后不良。对于这种高度选择性的局限性肿瘤,我们探索了将手术作为唯一治疗方法。本文回顾性分析和总结了这一系列病例的临床资料,旨在探讨主要的技术细节和临床预后。
纳入的患者为无神经纤维瘤病 1 型且患侧视力丧失的 OPG-uDCⅠ患者。采用额眶入路,主要分为 3 部分:眶内、视神经管和颅内。所有患者均行视交叉前切除术,不进行任何辅助治疗。术后随访 3 个月,术后每年复查磁共振成像和对侧视力。
所有 OPG-uDCⅠ病例均完整切除,无任何辅助治疗,随访期间无复发。病理结果显示,除 1 例成人患者为毛细胞型星形细胞瘤(世界卫生组织分级Ⅱ级)外,其余均为毛细胞型星形细胞瘤(世界卫生组织分级Ⅰ级)。5 例患者出现短暂性上睑下垂,术后 3 个月均恢复。
对于无神经纤维瘤病 1 型的 OPG-uDCⅠ,肿瘤的视交叉前根治性切除术是可能的,无需术后放化疗。